AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Karbohold GM 2mg/500mg/0.3mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Medxone Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Karbohold GM 2mg/500mg/0.3mg Tablet ER

Diabetol Plus ER (2mg/500mg/0.3mg) tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabetol Plus ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and how to treat them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Karbohold GM 2mg/500mg/0.3mg Tablet ER

Managing type 2 diabetes

Major Benefits of Karbohold GM 2mg/500mg/0.3mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Karbohold GM 2mg/500mg/0.3mg Extended-Release tablet whole; do not break, chew, or crush it. Administer on an empty stomach.

Common Side effects of Karbohold GM 2mg/500mg/0.3mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Karbohold GM 2mg/500mg/0.3mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Karbohold GM 2mg/500mg/0.3mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Karbohold GM 2mg/500mg/0.3mg Tablet ER works:

Extended-release Karbohold GM tablets (2mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Karbohold GM 2mg/500mg/0.3mg Tablet ER with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Karbohold GM 2mg/500mg/0.3mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Karbohold GM 2mg/500mg/0.3mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Extended-release Karbohold GM 2mg/500mg/0.3mg tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Moreover, their use is discouraged in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Individuals with liver impairment should use Karbohold GM 2mg/500mg/0.3mg Extended-Release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose of Karbohold GM 2mg/500mg/0.3mg Extended-Release tablets is typically recommended; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Karbohold GM 2mg/500mg/0.3mg Tablet ER :

Should you forget to take a Karbohold GM 2mg/500mg/0.3mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Karbohold GM 2mg/500mg/0.3mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Karbohold GM 2mg/500mg/0.3mg Tablet ER

Karbohold GM 2mg/500mg/0.3mg Extended-Release Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Karbohold GM 2mg/500mg/0.3mg ER tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Patients with known allergies to Karbohold GM 2mg/500mg/0.3mg Tablet ER components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis) should not use this medication.
Combining Karbohold GM 2mg/500mg/0.3mg Tablet ER with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Karbohold GM 2mg/500mg/0.3mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medicine properly and keep it out of reach of children, pets, and others.
Karbohold GM 2mg/500mg/0....
163
MRP 189
13% off